SLL (SMALL LYMPHOCYTIC LYMPHOMA)
Clinical trials for SLL (SMALL LYMPHOCYTIC LYMPHOMA) explained in plain language.
Never miss a new study
Get alerted when new SLL (SMALL LYMPHOCYTIC LYMPHOMA) trials appear
Sign up with your email to follow new studies for SLL (SMALL LYMPHOCYTIC LYMPHOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat blood cancers: experimental drug enters human testing
Disease control Recruiting nowThis early-phase study tests a new drug called ZE50-0134 in about 66 adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or certain low-grade lymphomas that have returned or not responded to prior therapies. The main goals are to check the drug's safety and how …
Matched conditions: SLL (SMALL LYMPHOCYTIC LYMPHOMA)
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control
Last updated May 17, 2026 03:56 UTC
-
New hope for Tough-to-Treat leukemia: phase 3 trial pits rocbrutinib against pirtobrutinib
Disease control Recruiting nowThis study tests a new drug, rocbrutinib, against another drug, pirtobrutinib, in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or not responded to prior treatments. About 306 adults will take one of the two pills daily to s…
Matched conditions: SLL (SMALL LYMPHOCYTIC LYMPHOMA)
Phase: PHASE3 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated May 11, 2026 20:51 UTC